The author addresses critical issues to consider prior to performing forced degradation studies and provides best practice recommendations for these types of studies.
Anette Skammelsen Schmidt
Advertisement
Articles by Anette Skammelsen Schmidt
Advertisement
Latest Updated Articles
Forced Degradation Studies for BiopharmaceuticalsPublished: July 1st 2016 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
